Search

everythinglearnresearchcommunity

for

Search:↓

Azathioprine may be an effective treatment for severe hair loss.

Dupilumab can both heal and cause hair loss.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Vitiligo patients are willing to pay the most for treatment, regardless of disease severity.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

Hair follicles prevent NK cell attacks to avoid hair loss.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

New treatments for hair loss show promise, but more development is needed, especially for tough cases.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Eosinophilic esophagitis may trigger alopecia areata in some patients.

New gene discoveries have improved diagnosis and treatment for skin and hair disorders, but more research is needed to fully understand them.

Lasers and light therapy are effective for treating skin conditions like hair loss, vitiligo, psoriasis, and molluscum contagiosum.

Both atopy and eosinophilia are linked to more severe hair loss in people with alopecia areata.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

Alopecia areata is a hair loss condition that often starts before age 30 and can affect various body parts, with unpredictable hair regrowth chances.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Understanding related health issues in skin disease patients is crucial for better care.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Reversing female hair loss.

Alopecia Areata is a hair loss condition affecting all genders, often linked to other diseases, with treatments available but varying success rates.

Some CAM therapies help with pediatric atopic dermatitis, but more research is needed.

The study concluded that tick infestation was the most common skin problem in hospitalized dogs in Chennai, with various treatments used for different conditions.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Most hospitalized children with skin issues were boys, with allergic skin diseases like atopic dermatitis being most common, and treatments were usually topical.

Children with atopic dermatitis often have sleep problems, affecting their growth and behavior.